GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Accounts Payable

J.Molner AS (OTSE:MOLNR) Accounts Payable : €0.27 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Accounts Payable?

J.Molner AS's Accounts Payable for the quarter that ended in Dec. 2023 was €0.27 Mil.

J.Molner AS's quarterly Accounts Payable declined from Dec. 2022 (€0.07 Mil) to Jun. 2023 (€0.06 Mil) but then increased from Jun. 2023 (€0.06 Mil) to Dec. 2023 (€0.27 Mil).

J.Molner AS's annual Accounts Payable declined from Dec. 2021 (€0.14 Mil) to Dec. 2022 (€0.07 Mil) but then increased from Dec. 2022 (€0.07 Mil) to Dec. 2023 (€0.27 Mil).


J.Molner AS Accounts Payable Historical Data

The historical data trend for J.Molner AS's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Accounts Payable Chart

J.Molner AS Annual Data
Trend Dec21 Dec22 Dec23
Accounts Payable
0.14 0.07 0.27

J.Molner AS Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Accounts Payable 0.14 0.22 0.07 0.06 0.27

J.Molner AS Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


J.Molner AS Accounts Payable Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


J.Molner AS (OTSE:MOLNR) Business Description

Traded in Other Exchanges
N/A
Address
Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618
J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines